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The central recombination enzyme RAD51 has been implicated in replication fork processing
and restart in response to replication stress. Here, we use a separation-of-function allele of
RAD51 that retains DNA binding, but not D-loop activity, to reveal mechanistic aspects of
RAD51’s roles in the response to replication stress. Here, we ﬁnd that cells lacking RAD51’s
enzymatic activity protect replication forks from MRE11-dependent degradation, as expected
from previous studies. Unexpectedly, we ﬁnd that RAD51’s strand exchange activity is not
required to convert stalled forks to a form that can be degraded by DNA2. Such conversion
was shown previously to require replication fork regression, supporting a model in which fork
regression depends on a non-enzymatic function of RAD51. We also show RAD51 promotes
replication restart by both strand exchange-dependent and strand exchange-independent
mechanisms.
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he complete and accurate replication of the genome is
essential to maintain genome integrity. Replication forks
face many obstacles that can result in replication fork
stalling or replication fork collapse. Proteins initially identiﬁed on
the basis of their roles in homologous recombination (HR) are
now known to have key functions during replication stress1,2. HR
proteins act to protect and remodel stalled replication forks, and
reconstruct functional replication forks following fork collapse.
As a result of these activities, HR proteins are critical to the ability
of cells to restart stalled and collapsed replication forks.
The central HR protein, RAD51, forms helical nucleoprotein
ﬁlaments on tracts of single-strand DNA (ssDNA), such as those
formed by nucleolytic processing of the DNA ends at the sites of
DNA double strand breaks (DSBs). Once RAD51 ﬁlaments form
on tracts of ssDNA, the protein alters the structure of the ssDNA,
allowing the nucleoprotein ﬁlament to catalyze a homology
search to identify an identical or nearly identical sequence in
duplex DNA, and then carry out exchange of the bound ssDNA
strand with the like strand of the homologous duplex3. In this
way, the homology search and strand exchange activity of RAD51
acts to form a homologous joint between a broken chromatid and
its intact sister chromatid, leading to accurate repair of the DSB.
In addition to its role in repair of DSBs, RAD51 has three
separate roles at stalled replication forks. First, RAD51 promotes
replication fork regression, a process that has also been referred to
as replication fork reversal4,5. Replication fork regression involves
branch migration in the direction opposite to replication to form a
Holliday junction-containing chicken foot structure. Second,
RAD51 protects tracts of newly synthesized DNA from degradation. Initial resection of the reversed forks by MRE11, EXO1, and
DNA2 produces a ssDNA overhang at regressed forks5,6. The
formation of a stable RAD51 ﬁlament on the resulting ssDNA
overhang prevents extensive degradation of regressed forks. In a
subset of tumor cell lines, nascent ssDNA degradation occurs in
cells with partial inhibition of RAD51 expression or activity in
response a variety of DNA damage agents7–12. Nascent DNA
degradation also occurs in cells lacking proteins required to load
RAD51 on ssDNA, such as BRCA1, BRCA2, FANCD2, and
the RAD51 mediators including RAD51C and XRCC25,7,12–16.
The degradation phenotype observed in these cells results from
the inefﬁcient nucleation and/or stabilization of RAD51 ﬁlaments
at the regressed fork5,15–17. Three nucleases involved in DNA end
resection, MRE11, EXO1, and DNA2 are responsible for the
degradation of nascent DNA strands. MRE11 and EXO1 degrade
forks in cells with defects in RAD51 ﬁlament formation and stabilization. DNA2 degradation has been observed under two conditions. First, mutant cells in which RAD51 is efﬁciently loaded
onto reversed forks, but ﬁlament stability is decreased results in
DNA2-dependent degradation18. Second, in U20S cells, prolonged
HU treatment results in DNA2-dependent degradation that
occurs even without manipulations that decrease RAD51 ﬁlament
stability6,11. Depletion of RADX, a single-stranded binding protein
that negatively regulates RAD51 at regressed replication forks,
prevents excessive MRE11- and DNA2-dependent degradation
that results from defects that reduce RAD51 ﬁlament formation or
RAD51 ﬁlament stability11. However, depletion of RADX did not
prevent DNA2-dependent degradation after prolonged HU
treatment, indicating degradation occurs independently of RAD51
ﬁlament stability. Finally, RAD51 plays a role in restart of stalled
or collapsed replication forks19. Collapse of replication forks may
sometimes occur as a consequence of collision of forks with a
single-strand nick in the template and has been to shown to occur
as a consequence of enzymatic cleavage of reversed forks by
structure-speciﬁc endonucleases including MUS8120–22. Repair of
the resulting DSB by HR to reinstate the replication fork requires
RAD51 and MRE11 activity19,23,24.
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Although it is clear that RAD51 is required for protection of
nascent DNA strands from MRE11, replication fork remodeling,
and fork restart, the molecular mechanisms underlying RAD51’s
role in each of these functions remains to be determined. One
particularly important question is whether and to what degree
RAD51’s homology search and strand exchange activity, i.e., it is
enzymatic activity, is required for each its roles during the
replication stress response. The ability of RAD51 to promote
nuclease protection at stalled forks and/or HR can be separated
from its ability to promote fork regression. Partial knockdown of
RAD51 resulted in MRE11-dependent degradation of replication
forks, but knockdown to low levels of RAD51 rescues fork
deprotection by preventing replication fork regression11. RAD51dependent replication fork regression is BRCA2-independent5,17
even though protection of regressed forks from pathological
degradation by MRE11 is BRCA2-dependent. In addition,
replication-associated sister chromatid exchange has been
observed in BRCA2-deﬁcient cells that display defects in DSBdependent HR and RAD51 immunostaining focus formation25.
Another important study showed cells that co-express RAD51
WT with RAD51 T131P, a dominant-negative allele of RAD51
that forms unstable nucleoprotein ﬁlaments due to constitutive
ATPase activity, are HR proﬁcient, undergo fork regression, but
do not protect forks from degradation by MRE11 or DNA25,11,18.
However, the ability of RAD51 T131P to speciﬁcally disrupt fork
protection is only seen in cells co-expressing RAD51 WT at a
ratio that delays RAD51 focus formation, but does not inhibit HR
(e.g., in heterozygous, patient-derived cells)18; RAD51 T131P
protein does not form immunostaining foci and high levels of
mutant protein inhibits focus formation of endogenous RAD51.
This ﬁnding suggests that RAD51 T131P partially inhibits the
function of wildtype RAD51 resulting in the observed separation
of function. Another mutant allele of RAD51, RAD51 K133R,
which is defective in ATP hydrolysis, was found to rescue
MRE11-dependent fork protection in FANCD2-deﬁcient and
BRCA2-deﬁcient cells. However, human RAD51 K133R retains
strand exchange activity in vitro26–28 and can promote signiﬁcant
amounts of HR in vivo, although human RAD51 K133Rmediated HR has only been observed in chicken DT40 cells27.
Given that RAD51 K133R lacks ATPase activity which is involved
in promoting ﬁlament disassembly26, it is possible that the HR
defect observed in human cells expressing the mutant protein
results from a post strand exchange block to RAD51 ﬁlament
disassembly rather than from a defect in strand exchange.
Together, these considerations led us to the conclusion that the
prior work which separated different functions of RAD51 during
replication stress did not speciﬁcally test the role of the protein’s
enzymatic homology search and strand exchange activity in any
of the protein’s replication-associated functions. In this context it
should be noted that both ensemble and single molecule biochemistry have shown that only 8 bp of homology are required
for meta-stable homology-recognition by the enzymatic activity
of RAD51 family strand exchange proteins29,30. Given the binding stoichiometry of RAD51 to DNA (1 protomer per 3 nucleotides), ﬁlaments too short to be detected as immunostaining foci
could, in principle, promote strand exchange at stalled replication
forks. Thus, we propose that strand exchange could be a residual
activity of partially defective RAD51 during replication stress,
even in cells defective in RAD51 focus formation, such as
BRCA2-deﬁcient cells.
During the strand exchange reaction, RAD51 utilizes two
distinct binding sites. RAD51 forms nucleoprotein ﬁlaments on
resected single-strand DNA via a high-afﬁnity binding site (site I).
The RAD51 nucleoprotein ﬁlament searches intact dsDNA for
homologous sequences by binding a second low afﬁnity binding
site (site II), consisting of a cluster of positively charged residues
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that lie on the interior surface of the helical ﬁlament31. This
cluster binds backbone phosphates of dsDNA regions being
searched, and also continues to bind the out-going ssDNA strand
once strand exchange occurs32. In Saccharomyces cerevisiae,
RAD51 containing mutations in site II (II3A) retains the ability to
form nucleoprotein ﬁlaments, but is fully defective in homology
search and strand exchange in vitro and highly defective in
mitotic HR in vivo31.
Here, we disrupt the secondary binding site on human RAD51
to determine the role of strand exchange activity in response to
replication stress, focusing on the well-studied human osteosarcoma epithelial cell line, U2OS. Our results provide deﬁnitive
evidence that the enzymatic activity of RAD51 is not required to
protect stalled forks from MRE11 degradation, as expected. Surprisingly, we also show the enzymatic activity is not required for
RAD51-dependent remodeling of stalled forks to a form that
permits DNA2-dependent degradation of nascent DNA. In contrast, we provide evidence that RAD51 promotes replication
restart by both strand exchange-dependent and strand exchangeindependent mechanisms. Cytological and knockdown experiments show that cells expressing a strand exchange-defective
form of RAD51 accumulate collapsed replication forks and
undergo frequent new origin ﬁring in response to HU-induced
replication stress.
Results
hsRAD51-II3A binds DNA, but is defective in D-loop formation. To characterize the molecular functions of human RAD51’s
DNA binding and strand exchange activities during replication
stress, we constructed an allele of human RAD51 corresponding
to the S. cerevisiae rad51-II3A allele31. The corresponding human
RAD51-II3A (hsRAD51-II3A) protein has three amino acid
residues, R130, R303, and K313 changed to alanines. To determine if the mutant human protein (hsRAD51-II3A) had the same
properties as its budding yeast counterpart, we puriﬁed
hsRAD51-WT and hsRAD51-II3A proteins (Supplementary
Fig. 1a). We analyzed the nucleoprotein ﬁlament forming and
strand exchange activities of the two forms of RAD51 using
biochemical assays. Using ﬂuorescence polarization (FP), we
measured binding of the two forms of the protein to a Alexa84tagged 84-nt ssDNA oligo33. Titration showed that the two
proteins have similar binding activities to this oligo, the apparent
Kd’s for hsRAD51-WT and hsRAD51-II3A were 57 ± 1 nM and
132 ± 5 nM, respectively (Fig. 1a). Thus, hsRAD51-II3A displays
only a modest DNA binding defect in this assay. Next, we
examined the homology search and strand exchange activity of
hsRAD51-II3A with a D-loop assay that employs a 90-nt singlestrand oligonucleotide and a 4.4-kb supercoiled plasmid carrying
a dsDNA sequence identical to the sequence of the oligonucleotide (Fig. 1b). In this assay, hsRAD51-II3A exhibited 840-fold less
D-loop activity compared to hsRAD51-WT (0.06% vs. 17% of
plasmid DNA forming D-loops, respectively). Together the
results demonstrate that, like its budding yeast counterpart,
hsRAD51-II3A retains DNA binding, but not strand exchange
activity in vitro.
Next, we asked if hsRAD51-II3A displays separation of
RAD51’s DNA binding and HR functions in vivo. hsRAD51WT and hsRAD51-II3A were expressed in U2OS cells and
expression of the endogenous RAD51 protein was repressed via
siRNA targeting of the 3′UTR of the RAD51 mRNA to less than
7% of that observed in the nonsilencing siRNA (siNS) control
(Supplementary Fig. 1b). Both hsRAD51-WT and hsRAD51-II3A
were expressed at the same level, which was approximately
ﬁvefold higher than that seen for the endogenous protein in the
siNS control (Supplementary Fig. 1b).

ARTICLE

To determine the extent to which the spontaneous distribution
of RAD51 differed in cells transfected with RAD51 expression
constructs from that observed with endogenous RAD51, we
counted RAD51 foci in unselected nuclei. RAD51 typically forms
a small number of nuclear immunostaining foci in the absence of
induced damage at sites of spontaneous DNA damage or the sites
of nonrepair-associated RAD51 oligomers. The number of
spontaneous RAD51 foci between cells slightly increased in cells
expressing hsRAD51-WT (1.5 ± 6.7 (mean ± STD) RAD51 foci/
cell) or hsRAD51-II3A (1.5 ± 4 RAD51 foci/cell), when compared
to siNS (0.7 ± 1.8 foci/cell in siNS cells; Fig. 1c, d). In addition, a
small subpopulation of hsRAD51-WT (3.4 ± 1.5%) and
hsRAD51-II3A (2.3 ± 1.3%) transfected cells contained an average
of 44 ± 14 elongated RAD51 ﬁbers with contour lengths of 0.5–3
microns long (Supplementary Fig. 1c). This type of staining
pattern was observed previously as a consequence of RAD51
overexpression and reﬂects binding of RAD51 to undamaged
DNA34. This analysis indicated that the level of expression of
RAD51 from transfection of siRNA resistant constructs causes
only a slight increase in the frequency of spontaneous foci.
Analysis of damage induced RAD51 foci provided evidence
that hsRAD51-II3A retains DNA binding activity in vivo.
Loading of RAD51 protein ﬁlaments on the 3′ ssDNA overhang
at resected DSBs in vivo is conventionally assayed by measuring
the number of RAD51 foci resulting from treatment of cells with
agents that induce DNA breaks, such as X-rays34–37. The number
of RAD51 foci signiﬁcantly increased after X-ray treatment of
siNS transfected cells (Fig. 1c, d; 11 ± 14.4 foci/cell IR vs. 0.7 ± 1.8
foci/cell). Cells depleted of RAD51 exhibited a fourfold reduction
in IR-induced RAD51 focus formation (2.5 ± 6 foci/cell; p < 0.005;
Mann–Whitney test). Cells transfected with hsRAD51-WT (9 ±
9.7 foci/cell) showed the same level of X-ray induced foci as the
siNS control (11 ± 14.4 foci/cell). Importantly, the number of IRinduced hsRAD51-II3A (9 ± 8.3) foci did not differ signiﬁcantly
from siNS or hsRAD51-WT controls. Together, these results
indicate hsRAD51-II3A retains signiﬁcant DNA binding activity
in vivo.
To determine if hsRAD51-II3A is defective in HR, we employed
the DR-GFP assay38. In this assay, HR generates a functional
green ﬂuorescent protein (GFP) allele following induction of a
chromosomal DNA break in one of the two defective copies of
GFP carried by the reporter cell line (Supplementary Fig. 1d).
DSBs were induced in the U2OS-DR-GFP cells by transfection
with a plasmid expressing the I-SceI endonuclease. HR efﬁciency
was then measured by ﬂow cytometry as the frequency of GFPexpressing cells. RAD51 depletion reduced HR efﬁciency 6-fold
compared to siNS controls (0.97 ± 0.1% GFP-positive cells siNS vs.
0.16 ± 0.03% siRAD51; p value < 0.05; t test; Fig. 1e). Expression of
hsRAD51-WT in RAD51-depleted cells increased the HR
efﬁciency by threefold compared to siRAD51 cells (0.49 ± 0.03
GFP-positive cells vs. 0.16 ± 0.03% siRAD51; p value < 0.005). In
contrast, hsRAD51-II3A did not increase HR efﬁciency
in RAD51-depleted cells (0.12 ± 0.09 % GFP positive cells vs.
0.16 ± 0.03%; p value = 0.6) indicating hsRAD51-II3A is defective
for HR-mediated repair of DSBs. Consistent with our biochemical
observations, these data indicate human hsRAD51-II3A is able to
form RAD51 nucleoprotein ﬁlaments with normal efﬁciency, but
is defective for HR in vivo.
hsRAD51-II3A protects forks from degradation by MRE11. We
next sought to elucidate the molecular function of RAD51’s
enzymatic activity during perturbed replication, using the
DNA ﬁber assay to measure the ability of cells treated with the
replication inhibitor HU to protect nascent DNA strands from
degradation. Nascent DNA undergoes MRE11-mediated
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Fig. 1 hsRAD51-II3A retains ssDNA binding activity, but is defective for HR. a Human RAD51 binding to ssDNA was determined by ﬂuorescence
polarization. Protein at various concentrations was incubated with ﬂuorescein-tagged 84-mer ssDNA (200 nM nucleotides or 2.4 nM molecules) in buffer
B and incubated at 37 °C for 30 min. Error bars represent standard error of the mean from triplicate experiments. The apparent Kd for hsRAD51-WT is 57 ±
1 nM, for hsRAD51-II3A is 132 ± 5 nM. b The D-loop activity of hsRAD51-WT and hsRAD51-II3A was measured in the presence of increasing concentrations
of protein. Upper panel: autoradiogram following electrophoretic separation of D-loops from free 32P-labeled ssDNA oligo substrate. Lower panel:
quantitation of the autoradiogram shown in the upper panel. Error bars represent standard error of the mean from triplicate experiments. c Images depict
immunostaining RAD51 in cells prepared for staining 8 h after a dose of 6 GY X-rays in the indicated samples. Green-RAD51 Blue-DNA. Scale bar = 5 μm.
d Quantitation of RAD51 foci after the indicated treatments. Red line represents the mean. N = 50 nuclei from two independent experiments. Values are
presented as mean ± STD. Statistical signiﬁcance was determined using Mann–Whitney test (e) DR-GFP assay. The percentage of GFP-positive cells in
each sample are graphed. Graph is the average from two independent experiments. hsRAD51-WT and hsRAD51-II3A samples were done in duplicate for
both experiments. Error bars represent standard deviation and values are presented as mean ± SD. Statistical signiﬁcance was determined using t test.
Source data are provided as a source data ﬁle

degradation in cells that have defects in RAD51 loading and/or
stabilization of RAD51 nucleoprotein ﬁlaments5,7,13,15,16.
MRE11-dependent fork degradation in FANCD2 and BRCA2deﬁcient cells can be rescued by overexpressing RAD517,13. We
determined if hsRAD51-II3A overexpression rescues fork degradation in U2OS cells depleted of FANCD2 after treatment with 4
mM HU for 5 h (Fig. 2a, Supplementary Fig. 2a). Consistent with
previous studies, we observed replication tract shortening in
FANCD2-depleted cells (0.55 ± 0.15 μm (mean ± STD) vs. 0.74 ±
0.16, p value < 0.0001, Mann–Whitney test). As expected,
4

treatment with mirin (0.78 ± 0.15 μm, p < 0.0001) and expression
of hsRAD51-WT (0.79 ± 0.18 μm, p < 0.001) restored replication
tracts to lengths observed without HU treatment13. Expression of
hsRAD51-II3A also restored replication tract length in FANCD2depleted cells. We veriﬁed this result by expressing hsRAD51-WT
and hsRAD51-II3A in a BRCA2-deﬁcient (VU423) ﬁbroblast cell
line, which has also been shown to undergo MRE11-dependent
degradation upon HU-induced stress39 (Fig. 2b). As expected,
HU treatment resulted in shortened replication tracts (0.84 ±
18 μm vs. 0.62 ± 23 μm, p value < 0.0001) that were rescued by
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Fig. 2 hsRAD51-II3A protects nascent strands from MRE11-dependent degradation. a Box plot represents the IdU/CldU ratio of tracts measured in FANCD2depleted U2OS cells after the indicated treatment. b Box plot represents the IdU/CldU ratio of tracts measured in BRCA2-deﬁcient ﬁbroblasts (VU423) after
the indicated treatment. Data represent at least 150 replication tracts from two independent experiments. Lines represent the median for each set of
measurements. Boxes represent 25th and 75th quartiles with Tukey whiskers (see methods for details). Source data are provided as a source data ﬁle

treatment with mirin (0.84 ± 16 μm), by expression of hsRAD51WT (0.85 ± 0.15 μm) and by expression of hsRAD51-II3A
(0.81 ± 0.19 μm). Taken together, these data indicate expression
of hsRAD51-II3A rescues MRE11-dependent degradation in HR
mutants with destabilized RAD51 ﬁlaments.
hsRAD51-II3A replication tracts undergo degradation by
DNA2. MRE11-dependent degradation in human cells can be
prevented by inhibiting replication fork regression or by stabilizing
RAD51 ﬁlaments on regressed forks7,13,15–17. To distinguish
between these two possibilities, we examined replication tract
lengths in hsRAD51-II3A expressing cells after prolonged HU
treatment. Prolonged exposure to HU (4 mM HU for 8 h) was
previously shown to result in nascent strand degradation by the
nuclease DNA2 in U2OS cells without manipulations that decrease
RAD51 levels or ﬁlament stability6. Under these conditions, DNA2dependent degradation is dependent on RAD51-mediated fork
regression6. As indicated by a previous study6, the ability of DNA2
to degrade forks after prolonged HU treatment can be used as a
readout of efﬁcient fork regression in U2OS cells8,11.
We examined fork degradation by pulsing cells with CldU
followed by IdU before treatment with HU for 8 h and measured
the ratio of IdU to CldU (Fig. 3a). In both siNS and hsRAD51WT expressing cells, prolonged HU treatment resulted in a
signiﬁcant reduction in the CldU:IdU ratio (0.68 ± 0.26 (mean ±
STD) μm to 0.48 ± 0.20 μm for siNS p value < 0.005, 0.71 ± 0.22
μm to 0.46 ± 0.20 μm for hsRAD51-WT p value < 0.005,
Mann–Whitney test). Reducing DNA2 expression restored ratios
to those observed in untreated samples. In contrast, treatment
with mirin did not result in a signiﬁcant change in the CldU:IdU
ratio in either siNS or hsRAD51-WT expressing cells (Fig. 3a,
Supplementary Fig. 2b). These results conﬁrm DNA2, and not
MRE11, is responsible for degradation under these conditions in
U2OS cells. Depletion of RAD51 did not result in tract
degradation under any treatment condition. These ﬁndings

conﬁrm that RAD51 remodels HU stalled replication forks to
provide a substrate for DNA2-mediated degradation in U2OS
cells6. hsRAD51-II3A expressing cells exhibited a signiﬁcantly
reduced CldU:IdU ratio (0.75 ± 0.62 μm to 0.62 ± 0.30 μm,
p value < 0.005) that was rescued by depletion of DNA2.
Treatment with mirin has no effect on the CldU:IdU ratio in
hsRAD51-II3A expressing cells. We obtained an equivalent result
when we measured total tract length after pulsing cells with CldU
(Supplementary Fig. 2c). These results conﬁrm that, in contrast to
expectation4, the enzymatic activity of RAD51 is not required
to remodel stalled replication forks to a form that is sensitive to
DNA2-mediated degradation.
Several proteins have been shown to catalyze fork regression in
response to hydroxyurea including the SNF2 family translocases
and the helicase FBH116,40,41. To determine if FBH1 functions in
hsRAD51-II3A expressing cells to mediate fork regression, we
examined replication tract lengths in hsRAD51-II3A expressing
cells depleted of FBH1 after prolonged HU treatment (Fig. 3b,
Supplementary Fig. 2d). As before, treatment of siNS transfected
cells with HU reduced the CldU:IdU ratio (0.89 ± 0.22 μm to 0.56
± 0.17, p < 0.0001). Depletion of FBH1 restored tract length to
those observed in untreated controls (0.82 ± 0.17 μm) indicating
FBH1 promotes DNA2-dependent degradation. As above, we did
not observe degradation in siRAD51 transfected cells under any
conditions. HU treatment of hsRAD51-WT (0.90 ± 0.22 μm to
0.52 ± 0.15, p < 0.0001) and hsRAD51-II3A (0.86 ± 0.17 μm to
0.54 ± 0.15, p < 0.0001) reduced the replication tract length and
FBH1-depletion restored replication tract length in both cell lines.
Thus, FBH1 promotes DNA2-dependent degradation in cells
lacking RAD51 enzymatic activity, but this activity of FBH1
depends on the DNA binding activity of RAD51.
hsRAD51-II3A is defective in replication fork restart. Previous
studies showed RAD51 is required for restart of replication forks
stalled by HU treatment19. Thus, we determined if the enzymatic
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activity of RAD51 is required to restart stalled replication forks
after treatment with HU for 5 and 8 h (Fig. 4). The siNS and
hsRAD51-WT transfected cells showed signiﬁcant levels of restart
after both 5 and 8 h of HU treatment; in siNS control cells 50 ±
5.5 % (mean ± SD) and 39 ± 3.9% of replication forks restarted
after 5 and 8 h of HU treatment respectively; in hsRAD51-WT
transfected cells, the corresponding numbers were 48 ± 3.3% and
40 ± 3.9%, respectively. Depletion of RAD51 resulted in a 2-fold
reduction in the frequency of restart at 5 h (24.3 ± 4.8% fork
restart; p < 0.005, t test) and a 2.3-fold reduction at 8 h (17.1 ±
2.4% fork restart; p < 0.005), conﬁrming that RAD51 is required
for efﬁcient fork restart after HU treatment. hsRAD51-II3A
expressing cells gave results that were intermediate between the
positive and negative controls, with only a slight decrease in the
efﬁciency of replication fork restart (44 ± 2.6%; p > 0.05) at 5 h
and a more severe (2.8-fold) reduction in the frequency of restart
after 8 h HU treatment (13.8 ± 2.7% fork restart; p < 0.005). Thus,
RAD51’s enzymatic activity is required for efﬁcient replication
restart, with a much greater requirement after 8 h as compared to
5 h of HU treatment. The results also raise the possibility that the
strand exchange defective form of RAD51 can promote more
restart than occurs when RAD51 levels are dramatically repressed. The alternative possibility is that hsRAD51-II3A has residual
strand exchange activity in vivo, in spite of our inability to detect
such activity biochemically. However, this seems unlikely because
hsRAD51-II3A did not exhibit higher HR activity in vivo using
the DR-GFP assay compared to RAD51-depleted cells (Fig. 1).
Next, we examined cells for new origin ﬁring following a
period of replication blockage by HU. New origin ﬁring can be
detected in the same double labeling experiments described
above, by the presence of tracts containing only IdU labeling. We
observed very little or no new origin ﬁring (<5%) in the positiveand negative-control experiments (Fig. 4). After 5 h HU
treatment, hsRAD51-II3A cells exhibited new origin ﬁring similar
to control cell lines. In contrast, hsRAD51-II3A expressing cells
exhibited a 6.3-fold higher level of new origin ﬁring at 8 h as
compared to siNS (19 ± 2.7%; p < 0.005). These data indicate that
6

replication fork blockage by HU leads to more new origin ﬁring
in cells expressing hsRAD51-II3A, than in cells expressing
hsRAD51-WT or in cells blocked for RAD51 expression.
After HU treatment, hsRAD51-II3A cells accumulate 53BP1
foci. Replication fork blockage by HU can lead to fork collapse, a
process that creates a broken DNA end that recruits DNA break
proteins including 53BP142–46. Replication stress-induced fork
collapse and associated DNA break signaling have been shown to
lead to the ﬁring of new origins19. Given prior evidence for a
functional association between new origin ﬁring and fork collapse, we hypothesized that the new origin ﬁring we observed in
HU-treated hsRAD51-II3A cells is a consequence of an increased
frequency of fork collapse. We, therefore, tested for evidence of
collapsed fork accumulation speciﬁcally in S-phase cells by
staining with 53BP1, which is known to localize to DSBs, and the
replication fork speciﬁc marker PCNA47,48. After 8 h in HU, the
siNS, hsRAD51-WT positive controls, and the siRAD51 negative
control, showed a 7-fold increase in the average number of 53BP1
foci/cell (20.5 ± 9.6 (mean ± SD) 53BP1 foci/cell compared to
2.9 ± 3.8 foci per cell prior to HU treatment; Fig. 5). Expression of
hsRAD51-II3A cells resulted in a signiﬁcantly greater (11-fold)
increase in 53BP1 foci after 8 h HU treatment (47 ± 0.8 53BP1
foci/cell; p value < 0.005, Mann–Whitney test) as compared to the
untreated sample. In addition to being recruited at broken DNA
ends formed by fork collapse, 53BP1 may form foci at DNA ends
of reversed forks (i.e., the middle toe of the chicken foot)45, and is
recruited to stalled forks early in the replication response49. As a
means of determining if the observed 53BP1 foci that accumulate
in RAD51-II3A expressing cells were due to fork collapse mediated by MUS81, we asked if the observed accumulation could be
reduced or eliminated by siMUS81 (Fig. 5, Supplementary Fig. 3).
Indeed, depletion of MUS81 reduced the number 53BP1 foci
in siNS, siRAD51, and hsRAD51-WT expressing cells 1.8-fold
(12.3 ± 7.3 foci/cell; p value < 0.005). In RAD51-II3A expressing
cells, MUS81 depletion resulted in a 1.9-fold decrease in the
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Fig. 4 Replication restart defects in hsRAD51-II3A expressing cells after treatment with HU. Graphs depict the percentage of replication forks that restart
after the indicated treatments (left) or the percentage of new origin ﬁrings (right). Graph is average of two independent experiments consisting of at least
100 replication tracts with error bars representing standard deviation. Values are presented as mean ± SD. Statistical signiﬁcance was determine using a t
test. Schematic of experimental design is above the graphs and ﬁbers that represent restarted forks (CldU + IdU), stalled fork (CldU only) and new origin
(IdU only) are shown. Source data are provided as a source data ﬁle

number of 53BP1 foci per nucleus (24.5 ± 11.8 foci/cell; p value <
0.005) providing evidence that 53BP1 focus formation is associated with MUS81-dependent cleavage. As a control against the
possibility that 53BP1 activity differs between cultures, a fraction
of each culture was treated with HU for 24 h. This highly prolonged replication arrest caused equivalent induction of 53BP1
foci and MUS81 depletion signiﬁcantly reduced 53BP1 foci in all
samples, as expected (Supplementary Fig. 3). Together, the results
suggest that hsRAD51-II3A causes more accumulation of collapsed forks following 8 h HU treatment than occurs in cells
expressing equivalent levels of hsRAD51-WT, and also more than
in cells expressing very low levels of RAD51. The possible
mechanistic basis for these observations is discussed below.
Discussion
RAD51 has been implicated in several steps in the response to
replication stress, including fork protection, replication fork
remodeling, and replication fork restart. Here, we utilized a
RAD51 mutant allele that retains DNA binding activity, but is
defective in strand exchange to gain mechanistic insight into the
role of RAD51’s enzymatic activity at stalled replication forks.
Previous studies have suggested that stabilization of RAD51
ﬁlaments is sufﬁcient to protect from MRE11-dependent degradation7,13. This study utilized the RAD51-K133R mutant that is
defective for HR-mediated repair, but has robust strand exchange
activity precluding the use of this mutant to deﬁnitively determine if RAD51 DNA binding activity alone is sufﬁcient to protect
from MRE11-dependent degradation26,27. We found that the
ability of RAD51 to protect nascent strands from MRE11mediated degradation is independent of strand exchange activity
in both BRCA2- and FANCD2-deﬁcient cell lines supporting the
hypothesis that RAD51 ﬁlament formation is sufﬁcient to protect
replication forks from pathological degradation. Our results
provide additional insight into the mechanism of RAD51dependent replication fork remodeling by showing that degradation of regressed forks by DNA2 does not require RAD51’s
enzymatic activity. We further show that the enzymatic activity of
RAD51 is required for efﬁcient replication restart after prolonged
HU exposure.

Prolonged HU treatment of cells results in DNA2-dependent
degradation that is not dependent on BRCA2-RAD51 fork protection, but depends on RAD51-dependent replication fork
regression6,11. We provide evidence that the enzymatic activity of
RAD51 is not required for DNA2-dependent degradation of
stalled forks under conditions of prolonged replication stress
suggesting that DNA binding activity of RAD51 is sufﬁcient to
promote replication fork regression. How can the DNA binding
activity of RAD51 promote replication fork regression? RAD51
interacts with polymerase α preventing the formation of ssDNA
gaps at stalled forks16. If annealing of complementary nascent
strands is important to drive fork regression, RAD51 preventing
signiﬁcant ssDNA formation at the fork may be sufﬁcient to drive
fork regression. Alternatively, DNA-bound RAD51 could promote
fork regression by recruiting other proteins that act directly to
catalyze the process. RAD5450, FANCM51, HTLF52, and
ZRANB353,54, have been found to be able to reverse a model
replication fork substrate in vitro and FBH140, SMARCL115, and
ZRANB341 have been shown to promote fork regression in vivo.
Here, we show FBH1 depletion in RAD51-II3A expressing cells
prevents DNA2-dependent degradation, providing evidence for a
pathway of fork regression that depends on both the nonenzymatic activity of RAD51 and on FBH1. Importantly, we see no
difference in the level of DNA2 sensitivity in cells blocked for
FBH1 expression when cells expressing RAD51-WT or RAD51II3A are compared. This ﬁnding implies that the enzymatic
activity of RAD51 cannot substitute for FBH1 in promoting fork
regression under these conditions. We cannot rule out the possibility that RAD51 enzymatic activity is capable of promoting fork
regression in other types of human cells, but that strand exchangeindependent mechanisms involving fork remodeling proteins such
as SMARCL1, ZRANB3, and FBH1 predominate in U2OS cells.
hsRAD51-II3A cells promoted signiﬁcant restart after 5 h HU
treatment, but were highly defective in replication restart after
longer (8 h) treatment with HU. Together, our results lead us to a
model for three distinct pathways to restart stalled replication
forks, one that is RAD51-dependent, strand exchange-dependent;
a second that is RAD51-dependent, strand exchange-independent; and a third that is RAD51-independent. Further, our results

NATURE COMMUNICATIONS | (2019)10:4410 | https://doi.org/10.1038/s41467-019-12297-0 | www.nature.com/naturecommunications

7

ARTICLE

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12297-0

+siMUS81

–siMUS81
53BP1

PCNA

DAPI

53BP1

PCNA

DAPI

siNS

siRAD51

siRAD51
+ RAD51-WT

siRAD51
+ RAD51-II3A

100

# 53BP1 foci

80

60

40

20

0
h HU (4 mM)

0 8 8

0 8 8

0 8 8

0 8 8

– – +

– – +

– – +

– – + siMU81

siNS

Fig. 5 hsRAD51-II3A expressing cells accumulate 53BP1 foci after treatment with HU. Representative images depicting 53BP1 foci (green) in PCNA (red)
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indicate that the RAD51-dependent, strand exchange-dependent
mechanism is more predominant after 8 h of exposure to HU as
compared to 5 h of exposure, while the converse is true for the
RAD51-dependent, strand exchange-independent mechanism.
These data are consistent with a previous study that identiﬁed an
early, cleavage-independent restart pathway involving 53BP1 and
a late, HR-dependent pathway involving BRCA149. Further studies are required to determine if the role of RAD51 early in the
replication stress response depends on 53BP1 or if this pathway
represents the RAD51-independent pathway identiﬁed by
our results. Our results are also consistent with work using an
allele of Schizosaccharomyces pombe rad51 that was modeled on
S. cerevisiae Rad51-II3A, but not biochemically characterized.
That work led to the proposal that strand exchange activity coded
by S. pombe rad51+ is dispensable for replication fork protection
from Exo1, but required for efﬁcient fork restart55.
Combining all the data, we propose the following model for
RAD51-dependent replication fork remodeling and restart
(Fig. 6). At early times after fork blockage, binding of RAD51 to
DNA is sufﬁcient to protect the replisome by preventing
8

excessive uncoupling of the replication fork; thereby preventing
signiﬁcant ssDNA accumulation. After fork regression and
processing of regressed arms by MRE11, EXO1, and/or DNA2,
RAD51 loading onto the regressed arm prevents pathological
degradation by nucleases. When the replication block is
removed, reversed forks can be resolved by the action of helicases such as RECQ1, reinstating the replication fork56. In
contrast, prolonged stalling of a replication fork results in the
formation of an intermediate that requires the strand exchange
activity of RAD51 for restart. One possibility is that MRE11and DNA2-mediated resection of the middle toe of the reversed
fork provides a single-stranded overhang that serves as a substrate for formation of a RAD51 nucleoprotein ﬁlament. In this
instance, RAD51-mediated strand invasion is used to reinstate
the replication fork. Alternatively, endonucleolytic cleavage of
reversed fork intermediates by nucleases such as MUS81 and
SLX1 may form collapsed fork structures containing singleended DNA breaks57,58. These structures are expected to
require RAD51-mediated strand exchange to restore functional
forks19. Consistent with this, hsRAD51-II3A expressing cells
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Here, we demonstrate RAD51 DNA binding activity alone is
sufﬁcient for replication fork protection and regression, but
strand exchange activity is required for a signiﬁcant fraction of
replication fork restart. Future work will determine precisely what
types of replication-associated structures require the strand
exchange activity of RAD51. It will also be of interest to determine if strand exchange activity of RAD51 has additional roles at
replication forks under conditions which require repair of a
physical lesion (e.g., interstrand cross-links), or conditions that
only result in a moderate reduction in replication fork speed (e.g.,
UV-light induced damage)10,18.
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Puriﬁcation of hsRAD51-WT and hsRAD51-II3A mutant. The open reading
frames of hsRAD51-WT and hsRAD51-II3A mutant with a C-terminal His-6 tag
were cloned into pET21d (Novagen). The proteins were overexpressed in Escherichia coli Rosetta(DE3) plysS cells by induction using 0.5 mM IPTG at 37 °C for 3
h. All the following steps for puriﬁcation were performed at 4 °C. Bacterial lysates
with expressed human RAD51 variants were generated by French press and cleared
by ultracentrifugation at 120,000×g for 30 min. The human RAD51 protein variants were then puriﬁed from the cleared lysates in sequential steps using nickel
columns (GE Healthcare) by gravity, followed by His-Trap FF in FPLC (GE
Healthcare). The eluted protein fractions were analyzed by 12% sodium dodecyl
sulphate polyacrylamide gel electrophoresis. The puriﬁed protein fractions were
pooled, concentrated by Amicon (Millipore), and exchanged into storage buffer
(25 mM Tris-HCl, pH 7.5, 1 mM DTT, 250 mM NaCl2, 0.5 mM EDTA, 10% glycerol) by PD10 column (Sephadex G25, GE Healthcare).
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5′
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5′
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Fig. 6 Model depicting role of RAD51 at stalled replication forks. RAD51
binds to a stalled replication fork and stabilizes it by preventing extensive
ssDNA formation. Proteins such as SMARCL1 and FBH1 promote replication
fork regression resulting in the formation of the chicken foot structure.
DNA2 resects the middle toe providing a substrate for RAD51 strand
exchange-dependent fork restart. DNA2 also promotes degradation of
nascent strands after fork regression in cells expressing hsRAD51-WT or
hsRAD51-II3A (not depicted). In RAD51-depleted cells (RAD51 KD), the
replication fork contains excess ssDNA due to uncoupling (Blue Box).
hsRAD51-II3A is able to prevent MRE11-degradation by binding directly to
the middle toe. hsRAD51-II3A is unable to restart the fork via strand
exchange activity resulting in trapped replication intermediate that often
consists of a one-ended DSB formed by MUS81-dependent cleavage of a
reversed fork. The one-ended DSB formed requires RAD51 strand exchange
activity to repair the break and reinstate the replication fork

accumulate 53BP1 foci that are dependent on MUS81 activity,
indicating that a substantial fraction of the accumulated foci
represents collapsed replication forks formed by MUS81 cleavage. hsRAD51-II3A expressing cells also exhibit increased
origin ﬁring. These phenotypes are associated with the accumulation of collapsed replication forks19. Interestingly, the
collapsed fork-associated phenotypes observed in hsRAD51II3A expressing cells are more severe than those observed in
RAD51-depleted cells. This observation suggests that replication fork remodeling mediated by hsRAD51-II3A traps replication intermediates that cannot be resolved by RAD51 strand
exchange-independent pathways. The partial dependency of
53BP1 foci on MUS81 suggests that a major fraction of the
trapped intermediates are collapsed forks, but it is possible that
the processing of unbroken reversed forks is also blocked by
RAD51-II3A, given prior evidence that 53BP1 can localize to
replication forks prior to DSB formation45,49.

DNA-binding assay. The binding of hsRAD51 to ssDNA was assayed by the FP
method in 50 µl. The ssDNA used was an 84-mer conjugated with Alexa Flour-488
at its 5′ end (5′GGTAGCGGTTGGGTGAGTGGTGGGGAGGGTCGGGAGGTG
GCGTAGAAACATGAT AGGAATGTGAATGAATGAAGTACAAGTAAA-3′;
synthesized by Integrated DNA Technologies) and was used at 200 nM nucleotides
(2.4 nM). Human Rad51 concentration range was from 10 to 1000 nM. The
binding reactions were in buffer B (25 mM Tris-HCl (pH 7.8), 1 mM MgCl2, 1 mM
ATP, 1 mM DTT, 50 mM NaCl2, 50 µM CaCl2, and 100 µg/ml bovine serum
albumin (BSA)). The reactions were initiated by adding protein to ssDNA and
incubated at 37 °C for 30 min. The FP (in mP units) was measured using a Tecan
Inﬁnite F200 PRO plate reader. All binding conditions were performed in triplicate,
and the mean values were plotted with standard error of the mean. Buffer and
ssDNA had no effect on FP in the absence of added protein; any background FP
from buffer or ssDNA has been subtracted from the corresponding values containing proteins.
D-loop assay. The assay was performed in 10 µl in a buffer containing 25 mM
Tris-HCl (pH 7.8); 1 mM MgCl2, 1 mM ATP, 1 mM DTT, 50 µM CaCl2, and 100
µg/ml BSA. 32P-90mer ssDNA (5′TACGAATGCACACGGTGTGGTGGGC
CCAGGTATTGTTAGCGGTTTG AAGCAGGCGGCAGAAGAAGTAACAAAG
GAACCTAGAGGCCTTTT) was used at 3.6 µM nucleotide or 40 nM; negative
supercoiled plasmid was pRS306 at 22 µM bp (5 nM); the concentrations of human
RAD51 protein variants were 0.5, 1, 1.5, and 2 µM and as indicated in Fig. 1b. In
the assay, human RAD51 was ﬁrst incubated with ssDNA at 37 °C for 10 min,
followed by the addition of 1 µl of supercoiled plasmid to initiate D-loop formation;
the mixture was incubated further at 37 °C for 15 min. The reaction was stopped by
adding a 2 µl mixture of sodium dodecyl sulphate (1% w/v) and protease K (1 mg/
ml) followed by incubation at 37 °C for 5 min for deproteinization. The samples
were analyzed by electrophoresis in 1% agarose gel in 1× TAE buffer. The gel was
dried onto a positively charged nylon membrane (Millipore), exposed to an image
plate, and analyzed using the Typhoon 9200 Phosphoimager (GE Healthcare) and
the computer software Quantity One. Quantiﬁcation of radioactive image intensities was performed with data within a linear range of exposure. The D-loop yield
was expressed as a percentage of input plasmid.
Cell culture. U2OS DR-GFP cells contain a stably integrated DR-GFP assay to
measure HR and was generated by the lab of Maria Jasin59. Cells were grown in
DMEM (Gibco) supplemented with 10% fetal bovine serum. The authenticity of
the cell line was validated previously by short tandem repeat proﬁling at the
Genetic Resources Core Facility at John Hopkins School of Medicine (Baltimore,
MD)60. Cell line was monitored monthly for mycoplasma contamination.
Expression of RAD51 in U2OS cells. WT RAD51 or RAD51 cDNA containing
mutations in the secondary binding site (R130A, R303A, and K313A) was cloned
into pcDNA 3.1 (Invitrogen) using Gibson assembly per manufacturer’s instructions (New England Biolabs).
The following primers were used to amplify the fragments used for cloning.
For ampliﬁcation of RAD51 cDNA:
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51_pcDNA_F 5′ tagcgtttaaacttaagcttGAATTGATCCATGGCAATG
51_ pcDNA_R 5’ctagactcgagcggccgccaCCCAATGATTCAGTCTTTG
For ampliﬁcation of pcDNA 3.1 vector:
pcDNA_F 5′ TGGCGGCCGCTCGAGTCT
pcDNA_R 5′ AAGCTTAAGTTTAAACGCTAGCCAGCTTGG
U2OS cells were transfected with pcDNA3.1, hsRAD51-WT (pNRB707), or
hsRAD51-II3A (pNRB708) expression plasmids using Lipofectamine 3000
(Invitrogen) as per manufacturer’s instructions. After 24 h, cells were transfected
with RAD51 siRNAs targeting the 3’UTR. At 48-hours post transfection, cells were
collected and analyzed for the various assays.
siRNA sequences. siRNAs were transfected using Lipofetamine RNAiMAX as per
manufacturer’s instructions (Invitrogen). The All-Star negative control (siNS)
siRNA was used as a control (Qiagen). The following siRNA sequences were used
in this study.
siRAD51 5′ GACUGCCAGGAUAAAGCUU was used in a previous study61.
siDNA2 5′ CAGUAUCUCCUCUAGCUAG was used in a previous study6.
siFANCD2 5′ CAGAGUUUGCUUCACUCUCUA was used in a previous study62
siMUS81 5′ CAGCCCUGGUGGAUCGAUA was used in a previous study63.
siFBH1 5′ GGAUGUUUGCAAGAGAGUCAGGAAA.
Nascent DNA ﬁber assay. Cells were pulsed with CldU (50 μM), or CldU (50 μM)
followed by IdU (150 μM) and treated with HU (4 mM) for the indicated times. To
measure replication restart, cells were pulsed with CldU (50 μM) before treatment
with 4 mM HU for the indicated times. HU was removed and cells were pulsed
with IdU (50 μM). Mirin (50 μM) was added 30 min prior to the pulse with CldU
and was present throughout the experiment. DNA ﬁbers were prepared by spotting
200–400 cells onto the slide. Cells were lysed and DNA ﬁbers were spread by tilting
slides. After drying for 1 h, slides were ﬁxed with 3:1 methanol:glacial acetic acid
and allowed to dry overnight. Slides were denatured in 2.5 M hydrochloric acid
before staining with antibodies to CldU and IdU. The primary antibodies used
were mouse anti-BrdU/IdU (1:50; B44, BD Biosciences) and anti-BrdU/CldU
(1:400, ab6326, Abcam) followed by staining with Alexa Fluor conjugated secondary antibodies (ThermoScientiﬁc, 1:1000). Tract lengths were measured using
Image J. The box plots represent pooled data from at least two independent
experiments. Box Plots were generated using Kaleidagraph software. Whiskers are
generated using the Tukey's method. First, the interquartile range (IQR) is calculated (the difference between the 25th and 75th percentiles). The whiskers represent the 75th percentile plus 1.5 times IQR and the 25th percentile minus 1.5 times
IQR. Statistical signiﬁcance was determined using Mann–Whitney test.

Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.

Data availability
Source data are provided as a source data ﬁle. All data supporting the ﬁndings of this
study are available from the corresponding authors upon request.
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